109145 ⎘
Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.
CATIONIC LIPIDS CONTAINING SILICON
#2102Modulatory polynucleotides
#2103KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#2104TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICS
#2105CORONAVIRUS IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#2106Compositions and methods for treating COVID-19
#2107CGAS/DNCV-LIKE NUCLEOTIDYLTRANSFERASES AND USES THEREOF
#2108COMPOSITIONS AND METHODS FOR REPROGRAMING NON-HEPATOCYTE CELLS INTO HEPATOCYTE CELLS
#2109EXTRAHEPATIC DELIVERY
#2110Treatment methods for fibrosis targeting SMOC2
#2111Targeting RNA viruses using inhibitors of METTL3
#2112Compositions and methods for regulating production of a fusion protein and ribonucleic acid
#2113IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS
#2114Polycomb-associated Non-Coding RNAs
#2115ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#2116Therapeutic alteration of transplantable tissues through or exposure to RNA interference molecules
#21175'-Cyclo-Phosphonate Modified Nucleotides
#2118PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#2119Methods of Detecting and Treating a Tumor Expressing PT346 PDK1
#2120METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2121RNAi Inhibition of Alpha-ENaC Expression
#2122Engineered immunostimulatory bacterial strains and uses thereof
#2123COMPOSITIONS AND METHODS FOR INDUCED TISSUE REGENERATION IN MAMMALIAN SPECIES
#2124METHODS FOR REDUCING POST-OPERATIVE COGNITIVE DYSFUNCTION (POCD)
#2125Nanoparticles comprising protein-polynucleotide complexes and for delivering protein based complexes
#2126NONCOVALENT TAGS AND RELATED METHODS FOR CYTOSOLIC DELIVERY OF MACROBIOMOLECULES
#2127HOMOLOGOUS RECOMBINATION DIRECTED GENOME EDITING IN EUKARYOTES
#2128Methods For Preventing Titration Of Bimolecular Templated Assembly Reactions By Structurally-Determined Differential Hybridizations
#2129A METHOD OF GENE EDITING
#2130Multi-targeted single entity conjugates
#2131HIGH VISCOSITY MACROMOLECULAR COMPOSITIONS FOR TREATING OCULAR CONDITIONS
#2132COMPOSITION, METHOD AND USE THEREOF
#2133DUAL FUNCTIONAL EXPRESSION VECTORS AND METHODS OF USE THEREOF
#2134REDUCING CD33 EXPRESSION TO SELECTIVELY PROTECT THERAPEUTIC CELLS
#2135COMPOSITION FOR DELIVERY OF GENETIC MATERIAL
#2136OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
#2137COMPOSITIONS AND METHODS COMPRISING HISTIDYL-TRNA SYNTHETASE SPLICE VARIANTS HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
#2138CATIONIC LIPID
#2139COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY
#2140PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION
#2141Targeted Nuclear RNA Cleavage and Polyadenylation with CRISPR-Cas
#2142IDENTIFICATION OF MOLECULAR PATHWAYS AND METHODS OF USE THEREOF FOR TREATING RETINAL NEURODEGENERATION AND OTHER NEURODEGENERATIVE DISORDERS
#2143Compositions and methods for reactivating latent immunodeficiency virus
#2144Methods and compositions for managing vascular conditions using miR-483 mimics and HIF1alpha pathway inhibitors
#2145COMPOSITIONS AND METHODS FOR INDUCED TISSUE REGENERATION IN MAMMALIAN SPECIES
#2146RNAi Agents for Inhibiting Expression of Alpha-ENaC And Methods of Use
#2147HNF4a saRNA compositions and methods of use
#2148Method of treating fatty liver disease
#2149METHODS AND COMPOSITIONS FOR ALTERING FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND/OR DOMAINS
#2150Complement component C5 iRNA compositions and methods of use thereof
#2151Products and compositions
#2152CELL PENETRATING MOLECULE
#2153RNA INTERFERENCE COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS
#2154COMPOSITIONS AND METHODS FOR CONTROLLING INSECT PESTS
#2155MODULATING PTPN2 TO INCREASE IMMUNE RESPONSES AND PERTURBING GENE EXPRESSION IN HEMATOPOIETIC STEM CELL LINEAGES
#2156RNAi agents for Hepatitis B virus infection
#2157SERPINC1 iRNA Compositions and Methods of Use Thereof
#2158SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS
#2159Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#2160Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#2161Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#2162Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#2163Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#2164Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#2165METHODS AND COMPOSITIONS USING RNA INTERFERENCE AND ANTISENSE OLIGONUCLEOTIDES FOR INHIBITION OF KRAS
#2166Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAs targeting the expanded hexanucleotide repeat
#2167APPLICATION OF PCSK9 INHIBITORS IN THE PREPARATION OF DRUGS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNE DISEASES
#2168Pharmaceutical composition for preventing or treating liver cancer
#2169COMPOSITIONS AND METHODS FOR INHIBITING HMGB1 EXPRESSION
#2170Application of ERH gene in the preparation of bladder cancer diagnosis and treatment products
#2171METHODS FOR TREATING PARKINSON'S DISEASE
#2172Double-stranded RNA molecule targeting CKIP-1 and use thereof
#2173RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF MYOTILIN
#2174DOUBLE-STRANDED NUCLEIC ACID INHIBITOR MOLECULES CONTAINING A TRILOOP
#2175Compounds and methods for reducing ATXN2 expression
#2176Compositions and methods of treating muscle atrophy and myotonic dystrophy
#2177NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOF
#2178USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER
#2179CONTROL OF INSECT INFESTATION
#2180METHODS OF DETECTING AND REDUCING CANCER CELL CENTRAL NERVOUS SYSTEM COLONIZATION
#2181MEANS AND METHODS FOR REDUCING TUMORIGENICITY OF CANCER STEM CELLS
#2182RNAi Agents for Inhibiting Expression of 17beta-HSD Type 13 (HSD17B13), Compositions Thereof, and Methods of Use
#2183Modified double-stranded RNA agents
#2184PROCESS TO INHIBIT OR ELIMINATE EOSINOPHILIC DISEASES OF THE AIRWAY AND RELATED CONDITIONS
#2185RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (SINA)
#2186Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2187CONTROL OF PLANT PESTS USING RNA MOLECULES
#2188COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES
#2189CHEMICALLY-MODIFIED RNAi CONSTRUCTS AND USES THEREOF
#2190Double-stranded oligonucleotide, composition and conjugate comprising double-stranded oligonucleotide, preparation method thereof and use thereof
#2191Treatment of staphylococcal disorders
#2192RNA nanoparticles and method of use thereof
#2193Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors
#2194Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a therapeutic strategy for Friedreich ataxia
#2195RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#2196PHARMACEUTICAL COMPOSITION THAT INHIBITS PRODUCTION OF HEPATITIS B VIRUS PROTEIN AND SCREENING METHOD
#2197INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#2198Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
#2199Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease
#2200Compositions and methods of treating muscle atrophy and myotonic dystrophy
#2201Compositions and methods of treating muscle atrophy and myotonic dystrophy
#2202LIPID COMPOSITIONS
#2203Compositions and methods for delivery of biomacromolecule agents
#2204Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts
#2205ADENO-ASSOCIATED VIRAL VECTORS FOR THE TREATMENT OF BEST DISEASE
#2206Targeting Ligands
#2207Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents
#2208COMBINATION THERAPY FOR TREATING MUSCULAR DYSTROPHY
#2209Methods for diagnosing and/or treating acute or chronic liver, kidney or lung disease
#2210Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2211METHODS OF TREATING SCHIZOPHRENIA AND OTHER NEUROPSYCHIATRIC DISORDERS
#2212Methods for preventing graft ischemia reperfusion injury during ex vivo machine perfusion preservation
#2213NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL8
#2214Compounds and methods for reducing prion expression
#2215Methods of Inhibiting Metastasis in Cancer
#2216Alpha-v beta-6 integrin ligands and uses thereof
#2217Ubiquitin-specific peptidase 24 inhibitor, medicinal composition including the same and method of delaying or reversing multidrug resistance in cancers using the same
#2218CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#2219Lipids and compositions for the delivery of therapeutics
#2220COMPOSITION FOR PREDICTING CHEMOTHERAPY RESISTANCE OF OVARIAN CANCER AND USE THEREOF
#2221RNAI STRATEGIES FOR CONTROL OF WHITEFLY
#2222RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF
#2223METHODS FOR IDENTIFYING THERAPEUTIC TARGETS AND TREATING AND MONITORING CANCERS
#2224ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF
#2225Compositions and methods for treatment of Friedreich's Ataxia
#2226METHODS AND COMPOSITIONS FOR TREATING A SERPINC1-ASSOCIATED DISORDER
#2227METHODS OF CANCER TREATMENT
#2228NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF C3 IN A CELL
#2229Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2230METHOD TO OBTAIN LOW TRITERPENE/TRITERPENOID-CONTAINING NATURAL RUBBER LATEX
#2231RNAI INDUCED REDUCTION OF ATAXIN-3 FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 3
#2232COMPOSITIONS AND METHODS FOR CONTROLLING ARTHROPOD PARASITE AND PEST INFESTATIONS
#2233METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND IDENTIFYING TARGETS THEREFORE
#2234Cell line with METTL3 gene knocked out, its construction method and interference vector
#2235Compositions and methods of treating muscle atrophy and myotonic dystrophy
#2236IDENTIFICATION OF JUND TARGET GENES FOR INHIBITION OF PROSTATE CANCER CELL GROWTH
#2237INHIBIN AS TARGETABLE REGULATORS OF ANGIOGENESIS
#2238Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseases
#2239MODIFIED DOUBLE-STRANDED RNA AGENTS
#2240NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL
#2241Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease
#2242COMPOSITIONS AND METHODS FOR CONTROLLING ARTHORPOD PARASITE AND PEST INFESTATIONS
#2243Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation
#2244COMPOSITIONS AND METHODS FOR MODULATING CANCER IMMUNE FITNESS
#2245Methods of Treating Influenza A Virus Infections
#2246PROGNOSIS AND TREATMENT OF METASTATIC CANCER
#2247Lipid nanoparticle formulations
#2248CONTROL OF COLEOPTERAN INSECTS
#2249Methods and compositions for determining pH
#2250Vector system for expressing regulatory RNA
#2251COPI COATOMER GAMMA SUBUNIT NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN AND HEMIPTERAN PESTS
#2252COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE
#2253Genetically modified mesenchymal stem cells for use in cardiovascular prosthetics
#2254Specific siRNA molecules, composition and use thereof for the treatment of triple negative breast cancer
#2255COMPOSITIONS AND METHODS FOR CONTROLLING INSECT PESTS
#2256Control of insect infestation
#2257Extended dicer substrate agents and methods for the specific inhibition of gene expression
#2258COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS D VIRUS INFECTION
#2259ENHANCED DENDRITIC CELL IMMUNE ACTIVATION BY COMBINED INHIBITION OF NR2F6 WITH CANNIBIDIOL
#2260POLYNUCLEOTIDE AGENTS TARGETING HYDROXYACID OXIDASE (GLYCOLATE OXIDASE, HAO1) AND METHODS OF USE THEREOF
#2261SiRNA conjugate, preparation method therefor and use thereof
#2262Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
#2263COMPOSITIONS AND METHODS FOR MODULATING EGG DEVELOPMENT IN MOSQUITOES
#2264VDAC1 SILENCING MOLECULES AND USE THEREOF
#2265Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#2266RNAI AGENTS FOR HEPATITIS B VIRUS INFECTION
#2267COMPOSITIONS AND METHODS FOR TREATING COVID-19
#2268CONTROL OF INSECT INFESTATION
#2269Monocarboxylate transporter (MCT) antisense oligonucleotide (ASO) inhibitors for use as therapeutics in the treatment of cancer
#2270Method and composition for inhibiting growth of bacterium
#2271Target-specific extracellular vesicles
#2272METHODS TO IMPROVE POTENCY OF ELECTROPORATION
#2273Compositions and methods for differentiation of human pluripotent stem cells into desired cell types
#2274Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
#2275MEDICAL DEVICES FOR DELIVERY OF siRNA
#2276FUS/TLS-BASED COMPOUNDS AND METHODS FOR DIAGNOSIS, TREATMENT AND PREVENTION OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED MOTOR NEURON DISEASES
#2277Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2278Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2279COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF PROTEIN C (PROC) GENES
#2280Extended dicer substrate agents and methods for the specific inhibition of gene expression
#2281Dosages and methods for delivering lipid formulated nucleic acid molecules
#2282Gene-regulating compositions and methods for improved immunotherapy
#2283METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS USING RNA NANOPARTICLES FOR CELL TRANSFORMATION
#2284GENE DELIVERY CARRIER
#2285BT TOXIN RECEPTORS AND METHODS OF USE
#2286Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
#2287Reducing Prominin2-Mediated Resistance to Ferroptotic Cell Death
#228817ß-Hydroxysteroid Dehydrogenase Type 13 (HSD17B13) iRNA Compositions And Methods Of Use Thereof
#2289Compositions and methods for inhibiting ALDH2 expression
#2290MULTIMERIC OLIGONUCLEOTIDES HAVING DECREASED KIDNEY CLEARANCE
#2291The long non-coding RNA INCA1 and Homo sapiens heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) as therapeutic targets for immunotherapy
#2292Myocardial enhancer RNA and methods of use
#2293Targeting metastasis stem cells through a fatty acid receptor (CD36)
#2294Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#2295GENE EDITING OF MONOGENIC DISORDERS IN HUMAN HEMATOPOIETIC STEM CELLS -- CORRECTION OF X-LINKED AGAMMAGLOBULINEMIA (XLA)
#2296METHODS OF INHIBITING PROLIFERATIVE CELLS
#2297COMPOSITIONS AND METHODS FOR DELIVERY OF AAV
#2298NUCLEIC ACID MOLECULES CONTAINING SPACERS AND METHODS OF USE THEREOF
#2299Biodegradable lipids for delivery of nucleic acids
#2300Method of delivering genes and drugs to a posterior segment of an eye
#2301Compositions and methods of treating Facioscapulohumeral muscular dystrophy
#2302METHODS OF TREATING MOTOR NEURON DISEASES
#2303RNAi nano-preparation, preparation method thereof and application thereof in TMV prevention and control
#2304Use of Non-Coding Nucleic Acid for Crop Improvement and Protection Against Microbes
#2305SARNA COMPOSITIONS AND METHODS OF USE
#2306OLIGONUCLEOTIDES FOR MAPT MODULATION
#2307ENGINEERED AAV CAPSIDS WITH INCREASED TROPISM AND AAV VECTORS COMPRISING THE ENGINEERED CAPSIDS AND METHODS OF MAKING AND USING SAME
#2308METHOD FOR PREVENTING OR TREATING CANCER USING SYT11 INHIBITOR
#2309Compositions and methods for treating transthyretin (TTR) mediated amyloidosis
#2310ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION AND THERAPEUTIC METHODS
#2311OLIGONUCLEOTIDES FOR MSH3 MODULATION
#2312Therapeutic and diagnostic methods relating to cancer stem cells
#2313METHODS AND COMPOSITIONS RELATING TO INHIBITING CARDIOVASCULAR CALCIFICATION VIA ANNEXIN A1
#2314Method of treating severe acute respiratory syndrome (SARS) virus infection by administering a protein disulfide isomerase (PDI) inhibitor
#2315PHARMACOPROTEOMICS PLATFORM IDENTIFYING KINOME FEATURES REGULATING DRUG RESPONSE IN CANCER
#2316Compositions and methods for treating beta-hemoglobinopathies
#2317Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1
#2318siNA MOLECULES, METHODS OF PRODUCTION AND USES THEREOF
#2319IMMUNOTHERAPY OF CANCER
#2320Compositions and methods for inhibiting expression of the LECT2 gene
#2321COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#2322Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2323Fibrotic treatment
#2324METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF RESPIRATORY INFECTIONS
#2325METHODS AND COMPOSITIONS TO INHIBIT METASTASIS AND TO TREAT FIBROSIS AND TO ENHANCE WOUND HEALING
#2326Oligonucleotides for tissue specific gene expression modulation
#2327Use of regulatory T cell-specific surface protein LRIG-1
#2328COMPOSITIONS AND METHODS FOR INHIBITING OR SCREENING FOR CD8 AND METHODS AND ASSAYS FOR DETECTING CD8 IN CELLS
#2329Method for preparing liposomes
#2330Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2331Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2332GENE THERAPIES FOR LYSOSOMAL DISORDERS
#2333USE OF CBX4 AS TARGET FOR ACTIVATION OF HIV-1 LATENT INFECTION
#2334KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#2335MINIATURIZED HAIRPIN RNAi TRIGGERS (mxRNA) AND METHODS OF USES THEREOF
#2336Compositions containing nucleic acid nanoparticles with modular functionality
#2337HIV pre-immunization and immunotherapy
#2338CCR7 aptamers and uses thereof
#2339Delivery across cell plasma membranes
#2340COMPOSITIONS AND METHODS FOR SEQUESTERING VIRUSES
#2341Methods and compositions for nucleic acid and protein payload delivery
#2342METHODS FOR IMPROVING PRODUCTION OF BIOLOGICAL PRODUCTS BY REDUCING THE LEVEL OF ENDOGENOUS PROTEIN
#2343AAV VECTORS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA
#2344SILENCING TGF-BETA 1 and COX2 USING siRNAs DELIVERED in a POLYPEPTIDE NANOPARTICLE ALONE and in COMBINATION with IMMUNE CHECKPOINT INHIBITORS to TREAT CANCER
#2345MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING HYPERTROPHIC CARDIOMYOPATHY
#2346MODULATING IMMUNE RESPONSES
#2347Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells
#2348MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
#2349METHODS AND COMPOSITIONS FOR INCREASING THE SUPPRESSIVE FUNCTION OF REGULATORY T-CELLS (TREGS)
#2350USE OF AKT INHIBITORS IN OPHTHALMOLOGY
#2351siRNA nanocapsule and preparation method and use thereof
#2352OLIGONUCLEOTIDE COMPOSITIONS FOR TARGETING CCR2 AND CSF1R AND USES THEREOF
#2353Oligonucleotides for PRNP modulation
#2354SERPINA1 iRNA compositions and methods of use thereof
#2355Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein
#2356NR2F6 INHIBITED CHIMERIC ANTIGEN RECEPTOR CELLS
#2357PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH POLYMETHINE DYE TARGETING
#2358Method for diagnosis, prognosis and determination of treatment for cutaneous t-cell lymphoma
#2359Angiotensinogen (AGT) iRNA compositions and methods of use thereof
#2360VARIANT RNAi AGAINST ALPHA-SYNUCLEIN
#2361Therapeutic and diagnostic target for SARS-CoV-2 and COVID-19
#2362Substituted imidazoles for preventing and/or treating cell or tissue necrosis
#2363MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FRIEDREICH'S ATAXIA
#2364METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYSTEMIC MASTOCYTOSIS
#2365Preparation and use of sugar-targeting nanoparticles for modifying SiRNA
#2366RNAi agents for inhibiting expression of PNPLA3, pharmaceutical compositions thereof, and methods of use
#2367Compositions of Asymmetric Interfering RNA and Uses Thereof
#2368Compositions and methods of treating Facioscapulohumeral muscular dystrophy
#2369Treatment Of Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, And Liver Fibrosis
#2370Ligase mutant
#2371Compositions and methods of treating muscle dystrophy
#2372Selective inhibition of T Follicular Helper cells for treatment of autoimmune disorders
#2373Inducing proliferation of cardiomyocytes and therapeutic uses related thereto
#2374COMPOSITIONS AND METHODS FOR REGULATING BODY WEIGHT AND METABOLIC SYNDROMES
#2375Compositions and methods for regulating body weight and metabolic syndromes
#2376CO-DELIVERY OF NUCLEIC ACIDS FOR SIMULTANEOUS SUPPRESSION AND EXPRESSION OF TARGET GENES
#2377COMPOSITIONS AND AGENTS AGAINST NONALCOHOLIC STEATOHEPATITIS
#2378Inhibition of protein kinases to treat Friedreich ataxia
#2379COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
#2380Exosomes and miRNA to treat glaucoma
#2381Extended dicer substrate agents and methods for the specific inhibition of gene expression
#2382METHOD OF TREATING CANCER
#2383Peptides for use as cell-penetrating peptides
#2384AMINE CATIONIC LIPIDS AND USES THEREOF
#2385Peptidic blocks for nucleic acid delivery
#2386Methods of treating PACS1 and PACS2 syndromes
#2387GFI1 INHIBITORS FOR THE TREATMENT OF HYPERGLYCEMIA
#2388METHODS OF SUPPRESSING DELIVERY OF EXOSOMES TO LIVER AND SPLEEN
#2389PDE3B VARIANTS
#2390Long double-stranded RNA for RNA interference
#2391COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION
#2392Compositions for Transfecting Resistant Cell Types
#2393METHODS OF PROMOTING CNS NEURONAL REPAIR BY INHIBITING LRP-1
#2394COMPOSITIONS AND METHODS OF ALLEVIATING RESISTANCE TO CHEMOTHERAPY
#2395Methods of treating cholangiocarcinoma
#2396Methods and compositions for treating asthma and allergic diseases
#2397AAV VARIANTS WITH ENHANCED TROPISM
#2398Methods and compositions for targeting PD-L1
#2399Targeting microRNA-101-3p in cancer therapy
#2400Nucleic acid, composition and conjugate comprising the same, and preparation method and use thereof